Telavancin for hospital-acquired pneumonia: clinical response and 28-day survival.

Journal Article

Full Text

Duke Authors

Cited Authors

  • Corey, GR; Kollef, MH; Shorr, AF; Rubinstein, E; Stryjewski, ME; Hopkins, A; Barriere, SL

Published Date

  • June 2014

Published In

Volume / Issue

  • 58 / 6

Start / End Page

  • 3581 -

PubMed ID

  • 24829393

Pubmed Central ID

  • 24829393

Electronic International Standard Serial Number (EISSN)

  • 1098-6596

Digital Object Identifier (DOI)

  • 10.1128/AAC.02899-14

Language

  • eng

Conference Location

  • United States